Charles L. Sidman, MBA, PhD, is an angel investor and Managing Partner of ECS Capital Partners, LLC, an innovative early-stage venture fund based in Bar Harbor, Maine, USA, but operating globally. He is a founding member of the American Angel Capital Association (ACA), past president of the Crowdfunding Professional Association (CfPA), a frequent advocate for, contributor to and speaker on financial, entrepreneurship, policy and ethical issues in Washington, D.C. and beyond, an enthusiastic member of and participant at EBAN, GBAN, NACO and numerous other professional organizations and networks, and a 2018 Special Recognition Honoree of EBAN. He invests in and supports early-stage companies throughout the world using private Angel investments, VC funds, Crowdfunding organizations and platforms, and the public markets.

Dr. Sidman retired as Professor of Molecular Genetics, Biochemistry and Microbiology from the College of Medicine at the University of Cincinnati, where he also served for many years as Professor of Management in the College of Business and in the university-wide Honors Scholars Program. His education includes a PhD in Immunology from Harvard University, an MBA specializing in Management from the University of Cincinnati, and sabbatical study in Complex Systems at the Santa Fe Institute.

About AAL2Business

AAL2Business is a three-year support action launched by the AAL Programme. Its main objective is to help companies in their business development and commercialisation challenges related to solutions developed under AAL projects. It offers a wide variety of support activities addressing AAL projects in different stages of their lifecycle: from before obtaining the funding until after the end of the project.